- In March 2024, Intuitive Surgical obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation multiport robotic system, da Vinci 5. This advanced robotic platform is expected to enhance surgical precision and improve patient outcomes. The approval marks a significant milestone for the company in advancing surgical technology
- In February 2024, Boston Scientific Corporation announced positive results from the National Institute for Health and Clinical Excellence (NICE) review on the safety and efficacy of endoscopic sleeve gastroplasty (ESG) using the OverStitch Endoscopic Suturing System. The findings confirmed that this minimally invasive weight loss procedure is safe for bariatric surgery. This review reinforces the potential of ESG as a viable alternative for patients seeking weight loss solutions
- In May 2023, Artivion, Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket application (PMA) approval for the PERCLOT Absorbable Hemostatic System (PerClot). This approval allows the product to be used for controlling bleeding in specific open and laparoscopic surgical procedures. The approval highlights the system’s effectiveness in enhancing surgical safety and improving patient outcomes
- In May 2023, Baxter announced that the U.S. Food and Drug Administration (FDA) granted premarket application (PMA) approval for its PERCLOT Absorbable Hemostatic System. This approval enables the use of PERCLOT for controlling bleeding during various surgical procedures. The approval underscores the system’s safety and effectiveness in enhancing surgical outcomes by managing bleeding more efficiently
- In June 2022, Johnson & Johnson Services, Inc. introduced the ECHELON 3000 Stapler in the U.S. This innovative, digitally enabled device offers surgeons enhanced precision with its simple, one-handed powered articulation. The launch of this stapler aims to improve surgical efficiency and accuracy, providing surgeons with greater control during procedures
